Question follow-through · 62829
Restless Legs Syndrome: Medical Treatments
To ask the Secretary of State for Health and Social Care, what assessment NHS England has made of the potential risks of dopamine agonists as a treatment for restless leg syndrome.
About this written question
A written question asks a government minister for information in writing. Parliament publishes the question and any answer.
- Answering body
- Department of Health and Social Care
- Tabled
- 25 Jun 2025
- Target answer date
- 30 Jun 2025
- Answer
- 3 Jul 2025 · 8 calendar days after tabling
Elapsed calendar days describe the record timeline, not whether Parliament considers an answer on time.
More questions by this MP on Health and care
- Neurodiversity: Diagnosis · 3 Jul 2025
- Neurodiversity: Women · 3 Jul 2025
- Breast Cancer: Health Services · 8 Jul 2025
- Breast Cancer: Health Services · 8 Jul 2025
- Dental Services: Finance · 15 Jul 2025
Shared topic keywords suggest a connection; they do not establish a follow-up.
Votes on this topic
- Terminally Ill Adults (End of Life) Bill: Second Reading · 11 Sept 2026
- Health Bill: Report Stage: Amendment 1 · 8 Sept 2026
- Health Bill: Report Stage: New Clause 143 · 8 Sept 2026
These Commons divisions share a topic label. The question did not necessarily lead to a vote.
Recorded timeline
25 Jun 2025
Question tabled
To ask the Secretary of State for Health and Social Care, what assessment NHS England has made of the potential risks of dopamine agonists as a treatment for restless leg syndrome.
30 Jun 2025
Target answer date
Date supplied by the official written-questions record.
3 Jul 2025
Answer published
NHS England has made no assessment. The Medicines and Healthcare products Regulatory Agency (MHRA) assesses all medicines before they are licensed in the United Kingdom, with regard to quality, safety, and efficacy. The licensed dopamine agonist medicines...
Official data retrieved 28 Sept 2026.
Later records
Possible follow-up questions
Strong links require the same MP, department and exact heading. Other same-department questions are shown as unreviewed candidates, not as confirmed follow-ups. No debate link is asserted unless a stable source relationship exists.
Neurodiversity: Diagnosis
3 Jul 2025 · To ask the Secretary of State for Health and Social Care, what assessment he has made of the gender gap in neurodiversity diagnosis in (a) Yeovil constituency, (b) Somerset and (c) England.
Neurodiversity: Women
3 Jul 2025 · To ask the Secretary of State for Health and Social Care, what steps he is taking to support research into how neurodiverse conditions manifest in women.
Breast Cancer: Health Services
8 Jul 2025 · To ask the Secretary of State for Health and Social Care, if he will implement the recommendations in Breast Cancer Now’s Setting the bar too high report in (a) Yeovil constituency and (b) the country.
Breast Cancer: Health Services
8 Jul 2025 · To ask the Secretary of State for Health and Social Care, what discussions he has had with NICE on the impact of their severity modifier on people with secondary breast cancer in (a) Yeovil constituency and (b) the UK.
Dental Services: Finance
15 Jul 2025 · To ask the Secretary of State for Health and Social Care, what proportion of the NHS budget was allocated to primary care NHS dentistry excluding patient charge revenue in each financial year since 2010-11; and what estimate he has made of the proportion
Dental Services: Finance
15 Jul 2025 · To ask the Secretary of State for Health and Social Care, how much funding his Department plans to provide for NHS dentistry in each of the next three financial years.
Dental Services: Finance
15 Jul 2025 · To ask the Secretary of State for Health and Social Care, what assessment the has made of the adequacy of the 1.68% uplift to the practice expenses element of the NHS dental contract in 2023-24, in the context of changes to the costs of running a dental p
Dental Services: Finance
15 Jul 2025 · To ask the Secretary of State for Health and Social Care, what recent discussions he has had with NHS dentists on rises in the costs for (a) NHS dental practices and (b) (i) laboratories and (ii) dental materials.
Cannabis: Medical Treatments
16 Jul 2025 · To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential merits of mandating digital prescribing for medical cannabis.
ADHD: Cannabis
16 Jul 2025 · To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential merits of prescribing medical cannabis as a treatment for the symptoms of attention deficit hyperactivity disorder.
Community Hospitals: Yeovil
16 Jul 2025 · To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential impact of the Ten Year Health Plan on community hospital bed provision in Yeovil constituency.
Neighbourhood Health Centres: Yeovil
16 Jul 2025 · To ask the Secretary of State for Health and Social Care, with reference to the 10 Year Health Plan for England, what assessment he has made of the potential impact of neighbourhood health centres on the provision of community hospital services in Yeovil